BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38302863)

  • 1. R-ketorolac ameliorates cancer-associated cachexia and prolongs survival of tumour-bearing mice.
    Chrysostomou SE; Eder S; Pototschnig I; Mayer AL; Derler M; Mussbacher M; Schauer S; Zhang D; Yan D; Liu G; Hoefler G; Weichhart T; Vesely PW; Zhang L; Schweiger M
    J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):562-574. PubMed ID: 38302863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia.
    Pototschnig I; Feiler U; Diwoky C; Vesely PW; Rauchenwald T; Paar M; Bakiri L; Pajed L; Hofer P; Kashofer K; Sukhbaatar N; Schoiswohl G; Weichhart T; Hoefler G; Bock C; Pichler M; Wagner EF; Zechner R; Schweiger M
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):93-107. PubMed ID: 36351437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.
    Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C
    Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles.
    Fan M; Gu X; Zhang W; Shen Q; Zhang R; Fang Q; Wang Y; Guo X; Zhang X; Liu X
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2724-2739. PubMed ID: 36085573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
    Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.
    Wu KC; Chu PC; Cheng YJ; Li CI; Tian J; Wu HY; Wu SH; Lai YC; Kao HH; Hsu AL; Lin HW; Lin CH
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2073-2087. PubMed ID: 35718751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia.
    Lu S; Li Y; Shen Q; Zhang W; Gu X; Ma M; Li Y; Zhang L; Liu X; Zhang X
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):779-795. PubMed ID: 33951335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EXT418, a novel long-acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice.
    Kerr HL; Krumm K; Lee II; Anderson B; Christiani A; Strait L; Breckheimer BA; Irwin B; Jiang AS; Rybachok A; Chen A; Caeiro L; Dacek E; Hall DB; Kostyla CH; Hales LM; Soliman TM; Garcia JM
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1337-1348. PubMed ID: 36942661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piceatannol, a Dietary Polyphenol, Alleviates Adipose Tissue Loss in Pre-Clinical Model of Cancer-Associated Cachexia via Lipolysis Inhibition.
    Kershaw JC; Elzey BD; Guo XX; Kim KH
    Nutrients; 2022 May; 14(11):. PubMed ID: 35684106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia.
    Weber BZC; Agca S; Domaniku A; Bilgic SN; Arabaci DH; Kir S
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1582-1594. PubMed ID: 35373517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide-induced hypothalamic inflammation in cancer cachexia-anorexia is amplified by tumour-derived prostaglandin E2.
    Li X; Holtrop T; Jansen FAC; Olson B; Levasseur P; Zhu X; Poland M; Schalwijk W; Witkamp RF; Marks DL; van Norren K
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3014-3027. PubMed ID: 36303458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
    Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone secretagogue receptor-1a mediates ghrelin's effects on attenuating tumour-induced loss of muscle strength but not muscle mass.
    Liu H; Zang P; Lee II; Anderson B; Christiani A; Strait-Bodey L; Breckheimer BA; Storie M; Tewnion A; Krumm K; Li T; Irwin B; Garcia JM
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1280-1295. PubMed ID: 34264027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDNF family receptor alpha-like antagonist antibody alleviates chemotherapy-induced cachexia in melanoma-bearing mice.
    Lee BY; Jeong J; Jung I; Cho H; Jung D; Shin J; Park JK; Park E; Noh S; Shin S; Kang S; Heo JI; Baek MC; Yea K
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1441-1453. PubMed ID: 37017344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel orthotopic mouse model replicates human lung cancer cachexia.
    van de Worp WRPH; Theys J; González AS; van der Heyden B; Verhaegen F; Hauser D; Caiment F; Smeets HJM; Schols AMWJ; van Helvoort A; Langen RCJ
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1410-1423. PubMed ID: 37025071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling.
    Chen X; Wu Y; Yang T; Wei M; Wang Y; Deng X; Shen C; Li W; Zhang H; Xu W; Gou L; Zeng Y; Zhang Y; Wang Z; Yang J
    J Cachexia Sarcopenia Muscle; 2016 May; 7(2):225-32. PubMed ID: 27493875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
    Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
    Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
    Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
    J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice.
    van Norren K; Kegler D; Argilés JM; Luiking Y; Gorselink M; Laviano A; Arts K; Faber J; Jansen H; van der Beek EM; van Helvoort A
    Br J Cancer; 2009 Mar; 100(5):713-22. PubMed ID: 19259092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia.
    Aquila G; Re Cecconi AD; Forti M; Frapolli R; Bello E; Novelli D; Russo I; Licandro SA; Staszewsky L; Martinelli GB; Talamini L; Pasetto L; Resovi A; Giavazzi R; Scanziani E; Careccia G; Vénéreau E; Masson S; Latini R; D'Incalci M; Piccirillo R
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.